IO Biotech
Industry:
Oncology
Website:
Company status:
Public
Description - IO Biotech is a clinical stage biotech company developing disruptive immune therapies for the treatment of cancer. Our pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules.
![Logo IO Biotech](/sites/default/files/images/portfolio/logo/io-biotech_0.jpg)